{
    "nct_id": "NCT04007601",
    "official_title": "Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)",
    "inclusion_criteria": "* Completed treatment for acute lymphoblastic leukemia (ALL) at SJCRH < 21 years at diagnosis\n* Enrolled on St. Jude Lifetime Cohort Study\n* ≥ 5 years post-diagnosis of ALL\n* ≥ 2 years post-treatment completion deemed to impact the central nervous system.\n* Currently between 18 and 39 years of age\n* English language proficiency\n* Executive dysfunction defined as having an age-adjusted standard score <16th percentile on Trail Making Test Part B, Controlled Oral Word association Test, or Digit Span Backward\n* Patient-reported executive dysfunction defined as a standard score >84th percentile on the Childhood Cancer Survivor Study Neurocognitive Questionnaire or the Behavior Rating Scale of Executive Function\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 39 Years",
    "exclusion_criteria": "* Full scale intelligence score <80\n* Currently taking medication intended to treat neurocognitive impairment (e.g. stimulants)\n* Participated in a past trial of neurostimulation\n* Female who is pregnant or breastfeeding\n* History of seizures within the past year\n* Implanted medical devices or metal in the head\n* History of head injury or a neurodevelopmental disorder (i.e. genetic disorder, hypoxic-ischemic encephalopathy) associated with neurocognitive impairment and unrelated to cancer treatment\n* Currently receiving cancer directed therapy",
    "miscellaneous_criteria": ""
}